I. Oliveira

Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches

C. Andrade, D. Macêdo, J. Barbosa-Filho, 2020, Behavioural Brain Research.

Gingerol Fraction from Zingiber officinale Protects against Gentamicin-Induced Nephrotoxicity

A. Havt, H. Monteiro, N. Alves, 2014, Antimicrobial Agents and Chemotherapy.

Subchronic administration of riparin III induces antidepressive‐like effects and increases BDNF levels in the mouse hippocampus

J. Barbosa-Filho, S. Vasconcelos, F. Sousa, 2015, Fundamental & clinical pharmacology.

Oral Manifestations of Drug Abuse: A Review of Literature

Maria Izabel Gomes Silva, L. F. Vasconcelos, A. Carvalho, 2020 .

Thymol reverses depression‐like behaviour and upregulates hippocampal BDNF levels in chronic corticosterone‐induced depression model in female mice

D. Macêdo, José Tiago Valentim, I. Oliveira, 2019, The Journal of pharmacy and pharmacology.

Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms

D. Macêdo, J. Barbosa Filho, José Tiago Valentim, 2018, Neurochemistry International.

Involvement of monoaminergic system in the antidepressant‐like effect of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice

D. Macêdo, S. Vasconcelos, F. Sousa, 2014, Fundamental & clinical pharmacology.

Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice

D. Macêdo, S. Vasconcelos, F. Sousa, 2019, Pharmacology Biochemistry and Behavior.

Is Riparin III a promising drug in the treatment for depression?

D. Macêdo, S. Vasconcelos, M. Fonteles, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.